Market Recap — May 5, 2026
Recap of insider activity, SEC filings, and market-moving news for May 5, 2026.
Top Importance Today
Filings and news with the highest AI-ranked importance score.
RenX Seeks Shareholder Approval for Over 8000% Potential Dilution from Recent Financings and Another Reverse Stock Split to Maintain Nasdaq Listing
ChronoScale Corporation Finalizes Business Combination, Secures $15.75M PIPE, and Reconstitutes Board
First Seacoast Bancorp Announces Definitive Merger Agreement with Cambridge Financial Group
First Seacoast Bancorp to be Acquired by Cambridge Financial Group in All-Cash $80.9M Merger at $17.25/Share
First Seacoast Bancorp to Merge with Cambridge Financial for $17.25 Cash Per Share
Shareholders Approve $21.00/Share Cash Merger; Closing Expected May 6, 2026
Dianthus Therapeutics Secures $777.7M in Capital, Extends Runway to 2030, and Receives Orphan Drug Designation
Avanos Medical to be Acquired for $25.00/Share in Definitive Merger Agreement
Bullish to Acquire Equiniti for $4.2 Billion, Targeting Global Tokenization Leadership
SmartKem Seeks Shareholder Approval for Massive Dilution, Reverse Stock Splits, and $500M Equity Line to Address Financial Distress
Scilex Subsidiary Sells ACEA Pharma for $1 Billion Stake in Phoenix Asia, Creating New Public Entity
Scilex Subsidiary Sells ACEA Pharma for $1B in Phoenix Shares, Gains 82% Stake in Nasdaq-Bound Entity
No high-importance items captured for this date.
Largest Open-Market Insider Buys
Form 4 open-market purchases ranked by dollar amount.
Sponsor Commits $3.55M in Private Placement Units Alongside IPO
Director & 10% Owner Marshall T. Reynolds Buys Nearly $1M in FGBI Stock, Reinforcing Insider Confidence
Clorox Director Buys $429K in Stock Near 52-Week Lows Amidst Recent Financial Headwinds
10% Owner Mountain Crest Holdings 6 LLC Buys $250K in Units Following IPO Close
CEO/CFO Suying Liu Buys $250K in Mountain Crest Acquisition 6 Shares Post-IPO
AI Era President Buys $111K in Stock, Boosting Holdings Amidst Convertible Note Financing
CFO Purchases $49,920 in Company Stock Following Compensation Award
CEO Ajay Amlani Buys $34.5K in AWRE Stock Amidst Recent Losses
No open-market insider buys reported on this date.
Largest Open-Market Insider Sells
Form 4 open-market sales ranked by dollar amount.
Director Sells Over $61 Million in FTAI Aviation Stock
Executive Chairman Sells Over $21.5 Million in Company Stock
Director Sells $13.1M in Shares to Company's Ongoing Repurchase Program
CEO Christopher Pappas Sells $9.75 Million in Company Stock
General Counsel Sells $6.7 Million in AAMI Stock Near 52-Week High
CEO Sells Over $912K in Company Stock Following Option Exercise
CEO Sells Over $557K in Company Stock Following Recent Positive News
10% Owner Sells Over $530K in Clene Inc. Stock Amidst Positive FDA News and Public Offering
CEO Sells $396K in Open Market, Liquidating Nearly All Direct Holdings
CEO Sells $215K in Shares Amidst Company Stock Repurchase Program
No open-market insider sells reported on this date.
Notable 8-Ks and News
Material events and breaking news with importance score 6 or higher.
First Seacoast Bancorp to Merge with Cambridge Financial for $17.25 Cash Per Share
Scilex Subsidiary Sells ACEA Pharma for $1 Billion Stake in Phoenix Asia, Creating New Public Entity
Scilex Subsidiary Sells ACEA Pharma for $1B in Phoenix Shares, Gains 82% Stake in Nasdaq-Bound Entity
Farmer Brothers Completes Take-Private Merger with Royal Cup at $1.29/Share; Delisting Imminent
Merck Completes Acquisition of Terns Pharmaceuticals; Shares to Delist
Momentus Forecasts 9X Revenue Growth, Secures $5M Private Placement, and Eliminates All Debt
Digi Power X Lands $1.1 Billion AI Colocation Deal for 40 MW Alabama Data Center
$375M Public Offering Priced at $17.75, Signaling Significant Dilution for Avalo Therapeutics
$36.5M Capital Infusion Secured by Citius Oncology to Accelerate LYMPHIR Launch
Jacobs Lifts 2026 Profit Forecast on Robust AI Infrastructure Demand, Beats Q2 EPS
No notable 8-Ks or news items on this date.
Form 144 Notices
Notices that restricted shares may be sold soon — often a precursor to insider selling.
CEO Earl Austin Jr. Files Intent to Sell $123.3M in Company Stock
Knowles Officer & Director Files Intent to Sell $4.75M in Shares Amidst Strong Performance
AIG Files Form 144 to Sell $724.5M in Corebridge Financial Shares
Chairman Files Intent to Sell $2.3M in Shares Amidst Company Buyback Program
Major Shareholder Atlas Venture Files Intent to Sell $28M in Dyne Therapeutics Stock
CEO Christopher Pappas Files Intent to Sell $9.85M in Shares
Officer Files Intent to Sell $5.28M in Shares, Following Recent $3.16M Sale
Former Affiliate Daniel Goldberger Files Intent to Sell $168K in Shares Amid Ongoing Sales
No Form 144 notices filed on this date.
Day boundary: 00:00 ET (America/New_York). Filings accepted late may appear in the next day's recap.